Lactobacillus rhamnosus LRa05 on glycemic control and gut microbiota in patients with type 2 diabetes.
- 2025-07-15
- RCT
- World journal of diabetes 16(7)
- Lin Geng
- Ting-Ting Sun
- Wen-Bo Xia
- Yin Qin
- Di Huo
- Guang-Jing Qu
- PubMed: 40697596
- DOI: 10.4239/wjd.v16.i7.106821
- High evidence
Additionally, fasting blood glucose was significantly reduced in the LRa05 group compared with the placebo group (P < 0.001).
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- 0.1 g 2 × 10^10 CFU